Eli Lilly Receivables 2010-2024 | LLY

Eli Lilly receivables for the quarter ending June 30, 2024 were $13.079B, a 42.61% increase year-over-year.

  • Eli Lilly receivables for 2023 were $11.336B, a 32.45% increase from 2022.
  • Eli Lilly receivables for 2022 were $8.559B, a 5.31% increase from 2021.
  • Eli Lilly receivables for 2021 were $8.127B, a 17.29% increase from 2020.

Eli Lilly Receivables 2010-2024 | LLY

  • Eli Lilly receivables for 2023 were $11.336B, a 32.45% increase from 2022.
  • Eli Lilly receivables for 2022 were $8.559B, a 5.31% increase from 2021.
  • Eli Lilly receivables for 2021 were $8.127B, a 17.29% increase from 2020.
Related Stocks
Company NameMarket
Cap
Johnson & Johnson (JNJ)$450.1B
Novo Nordisk (NVO)$424.5B
Merck (MRK)$270B
AbbVie (ABBV)$264.1B
AstraZeneca (AZN)$218.5B
Novartis AG (NVS)$218.4B
Pfizer (PFE)$201.2B
Sanofi (SNY)$133B
Innoviva (INVA)$953M